ARCHIVES

FDA Requires Independent Confirmation of Disease Progression in Cooperative Group Trials; Seeks Documentation for Avastin in Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

ACS: Decline in Death Rates Saved Over 1.3 Million Lives

January 10, 2014

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

April 30, 2010

In Brief: Carnegie Mellon President Emeritus honored By UPCI; Schiffer Leaves Maryland for Detroit

October 17, 1997

Biotheraputices To Reveal Plans for Expansion

August 8, 1986

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

NCI To Spend About $150 Mil. On Cancers That Affect Only Women

April 26, 1991